Table 3.
U.S. born | Foreign born | |||
---|---|---|---|---|
English-speaking % (95% CI) |
Non-English-speaking % (95% CI) |
English-speaking % (95% CI) |
Non-English-speaking % (95% CI) |
|
Influenza vaccination (2011–12 season)a | ||||
18+ | 40.5 (39.5, 41.6) | 25.6 (17.6, 36.5)* | 37.4 (35.0, 39.8) | 26.0 (22.8, 29.7)* |
Pneumococcal vaccination (ever received) | ||||
18–64 with high-risk conditions | 20.8 (19.6–22.0) | 21.0 (11.2–35.9) | 15.5 (12.9–18.5) | 9.9 (6.6–14.5)* |
65+ | 62.7 (61.0–64.3) | --b | 44.6 (40.0–49.1) | 30.5 (24.4–37.4)* |
Tetanus vaccination (past 10 yrs) | ||||
18+ | 65.1 (64.3–66.0) | 53.2 (45.4–60.9)* | 52.7 (50.8–54.6) | 46.2 (43.1–49.2)* |
Tetanus vaccination including pertussis vaccine (past 7 yrs) | ||||
18+ | 15.5 (14.8–16.3) | 11.8 (6.6–20.2) | 11.5 (10.2–13.0) | 4.6 (3.3–6.5)* |
Hepatitis A vaccination (≥ 2 doses) | ||||
18–49 among travelers | 19.8 (18.1–21.7) | 25.2 (14.7–39.6) | 19.3 (16.5–22.4) | 10.9 (7.7–15.0)* |
Hepatitis B vaccination (≥ 3 doses) | ||||
18–49 | 37.2 (36.1–38.3) | 38.9 (30.6–47.9) | 34.6 (31.7–37.6) | 16.0 (13.7–18.7)* |
18+ with diabetes | 20.8 (18.8–22.9) | --b | 29.2 (23.0–36.3) | 13.6 (9.0–20.2)* |
Shingles vaccination (ever received) | ||||
60+ | 21.3 (20.2–22.5) | --b | 15.0 (12.1–18.4) | 4.9 (2.8–8.5)* |
Human papillomavirus vaccination (≥ 1 dose) | ||||
18–26 Male | 4.0 (2.8–5.6) | --b | --b | --b |
18–26 Female | 39.1 (36.2–42.0) | 24.0 (14.1–37.7)* | 17.3 (12.1–24.0) | --b |
Note: Boldface indicates significance.
Abbreviations: CI=Confidence interval.
Influenza vaccination coverage estimates are based on interviews conducted during September 2011 through June 2012, and vaccination received during August 2011 through May 2012.
Estimates are not reliable due to sample size < 30 or relative standard error (RSE) > 30%.
p < 0.05 by t-test (English-speaking vs. non-English-speaking).